Cargando…
Answering human papillomavirus vaccine concerns; a matter of science and time
Since the introduction of the HPV vaccine, questions have been asked about its efficacy in preventing cancer linked with HPV. Concerns about the HPV vaccine safety profile have also been raised. This paper highlights the rapidly growing body of evidence (including clinical trials and post-marketing...
Autores principales: | Hawkes, David, Lea, Candice E, Berryman, Matthew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691750/ https://www.ncbi.nlm.nih.gov/pubmed/23758825 http://dx.doi.org/10.1186/1750-9378-8-22 |
Ejemplares similares
-
Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
por: Taumberger, Nadja, et al.
Publicado: (2022) -
Why Human Papillomavirus Acute Infections Matter
por: Alizon, Samuel, et al.
Publicado: (2017) -
Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
por: Sonawane, Kalyani, et al.
Publicado: (2021) -
The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety
por: Fonteneau, Laure, et al.
Publicado: (2015) -
Science: the ultimate answer
por: Rees, M
Publicado: (2001)